Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. SI
SI logo

SI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Shoulder Innovations Inc (SI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
13.050
1 Day change
-2.54%
52 Week Range
17.940
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Shoulder Innovations Inc (SI) is not a strong buy at this time for a beginner investor with a long-term strategy. While the company has shown impressive revenue growth and improvement in net income, its financials remain negative, with a net loss and declining gross margin. The technical indicators suggest a bearish trend, and there are no significant positive trading signals or catalysts to justify immediate action. Analysts are optimistic with a raised price target, but the lack of recent news or influential trading activity makes this stock a hold rather than a buy.

Technical Analysis

The technical indicators show a bearish trend. The MACD is above zero but contracting, suggesting weakening momentum. The RSI is neutral at 38.381, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point of 13.225, with resistance at 13.66 and support at 12.789.

Positive Catalysts

  • The company has shown strong revenue growth of 57.71% YoY and significant improvement in net income and EPS. Analysts have raised the price target to $20 with a Buy rating, indicating optimism about future performance.

Neutral/Negative Catalysts

  • Gross margin has slightly declined, and technical indicators suggest a bearish trend. There is no recent news or significant trading activity from insiders, hedge funds, or Congress.

Financial Performance

In Q3 2025, revenue increased by 57.71% YoY to $11.76M. Net income improved by 115.27% YoY but remains negative at -$8.73M. EPS improved by 220% YoY to -0.64, but gross margin dropped slightly to 69.69%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Goldman Sachs recently raised the price target to $20 from $19 and maintained a Buy rating, citing a return to normalized patterns and organic growth driving valuation in 2026.

Wall Street analysts forecast SI stock price to rise
3 Analyst Rating
Wall Street analysts forecast SI stock price to rise
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 13.390
sliders
Low
20
Averages
22
High
23
Current: 13.390
sliders
Low
20
Averages
22
High
23
Goldman Sachs
Buy
maintain
$19 -> $20
AI Analysis
2026-01-09
Reason
Goldman Sachs
Price Target
$19 -> $20
AI Analysis
2026-01-09
maintain
Buy
Reason
Goldman Sachs raised the firm's price target on Shoulder Innovations to $20 from $19 and keeps a Buy rating on the shares. After a year when fundamentals diverged from stock performance, 2026 should represent a return to normalized patterns where organic growth defines relative valuation, the analyst tells investors in a research note.
Morgan Stanley
Overweight
maintain
$18 -> $23
2025-12-02
Reason
Morgan Stanley
Price Target
$18 -> $23
2025-12-02
maintain
Overweight
Reason
Morgan Stanley raised the firm's price target on Shoulder Innovations to $23 from $18 and keeps an Overweight rating on the shares. Going into 2026, MedTech "looks well-positioned on several fronts" as the firm thinks major product cycles and a supportive hospital spending environment, combined with trough valuations, make for "a solid industry setup," the analyst tells investors in a note for the group on the upcoming year.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SI
Unlock Now

People Also Watch